vidarabine has been researched along with Cancer of Gastrointestinal Tract in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Omuro, Y; Sasaki, T | 1 |
| Alinari, L; Baccarani, M; Gabriele, A; Marchi, E; Musuraca, G; Pileri, S; Stefoni, V; Tani, M; Zinzani, PL | 1 |
| Katakkar, SB; Khaliq, A; LePage, GA; Naik, SR | 1 |
3 other study(ies) available for vidarabine and Cancer of Gastrointestinal Tract
| Article | Year |
|---|---|
[Gastrointestinal cancer].
Topics: Adult; Aged; Cyclophosphamide; Female; Gastrointestinal Neoplasms; Graft vs Host Disease; Graft vs Tumor Effect; Humans; Immunosuppressive Agents; Male; Middle Aged; Retrospective Studies; Stem Cell Transplantation; Transplantation Chimera; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Vidarabine | 2003 |
Fludarabine-containing chemotherapy as frontline treatment of nongastrointestinal mucosa-associated lymphoid tissue lymphoma.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; DNA (Cytosine-5-)-Methyltransferases; Female; Gastrointestinal Neoplasms; Humans; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Survival Rate; Treatment Outcome; Vidarabine; Vincristine | 2004 |
9-beta-D-arabinofuranosyladenine 5'-phosphate metabolism and excretion in humans.
Topics: Adenocarcinoma; Adenosine Monophosphate; Aged; Carcinoma; Female; Gastrointestinal Neoplasms; Humans; Injections, Intravenous; Male; Melanoma; Middle Aged; Neoplasms; Time Factors; Vidarabine | 1975 |